Zolmitriptan (a 5-HT receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder

ISSN： 0033-3158

Source： Psychopharmacology, Vol.152, Iss.1, 2000-09, pp. : 74-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT 1D agonist sumatriptan

By Stern L. Zohar J. Cohen R. Sasson Y.

European Neuropsychopharmacology, Vol. 8, Iss. 4, 1998-12 ,pp. : 325-328

Elsevier

Access to resources Recommend Favorite

Sumatriptan, 5-HT 1D receptors and obsessive-compulsive disorder

By Koran L.M. Pallanti S. Quercioli L.

European Neuropsychopharmacology, Vol. 11, Iss. 2, 2001-04 ,pp. : 169-172

Elsevier

Access to resources Recommend Favorite

Cranial vascular effects of zolmitriptan, a centrally active 5-HT 1B/1D receptor partial agonist for the acute treatment of migraine

By MacLennan S.J. Cambridge D. Whiting M.V. Marston C. Martin G.R.

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 191-197

Elsevier

Access to resources Recommend Favorite

Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder

By Jonkers Frits de Haan Lieuwe

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 87-88

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine and obsessive-compulsive symptoms

By Lykouras L. Zervas I.M. Gournellis R. Malliori M. Rabavilas A.

European Neuropsychopharmacology, Vol. 10, Iss. 5, 2000-09 ,pp. : 385-387

Elsevier

Access to resources Recommend Favorite